Fast Facts on Rabbit Hemorrhagic Disease

Rabbit hemorrhagic disease is a highly infectious fatal viral hepatitis affecting lagomorphs, including the European rabbit. There are three major pathogenic RHDV genotypes: classical RHDV (RHDV1), RHDVa, which is closely related to RHDV1, and rabbit hemorrhagic disease virus type 2 (RHDV2). RHDV2 has now become the dominant subtype in endemic countries, and sporadic cases have been confirmed in North America. Use “Fast Facts” to review the basics of this condition, from etiologic agent, pathogenesis, and clinical signs to diagnosis, prevention, and control.

Client Education Handout 

Rabbit Hemorrhagic Disease Virus

The objective of this resource is to educate pet rabbit owners about rabbit hemorrhagic disease. The reader will review the distinction between rabbit hemorrhagic disease virus type 1 and type 2, as well as the basics of disease transmission, signs of disease, diagnosis, prevention and control. Download the PDF version of this client education handout, or modify the DOCX version  for your veterinary hospital.

Article  Webinar 

Rabbit Hemorrhagic Disease and Vaccination

This live webinar event by Dr. Amanda Jones was RACE approved for 1 hour of continuing education. This presentation reviewed the history, pathobiology and transmission of rabbit hemorrhagic disease virus. Dr. Jones also reviewed vaccines available in Europe and North America. The target audience for this presentation was primarily North American veterinary health professionals, but there useful information was provided for anyone interested in this disease. Stay Tuned: A RACE-approved webinar recording will be available soon.

Article 

2021 AEMV Veterinary Medical Student Case Report Contest

Lafeber Company was proud to sponsor the 2021 Association of Exotic Mammal Veterinarians Student Case Report Contest. Veterinary medical students from all over the world were encouraged to write a 2-page case report about an exotic companion mammal seen at their college of veterinary medicine or during a clinical experience. Submissions closed in March and judges from the Research Committee evaluated the case reports received from seven nations. Judges were blinded to the students, mentors, co-authors, and institutions at which the cases were seen. Read the summary of each winning case report.